Key facts: Evonik rejects BASF bid; shares fall 23%; restructuring

Evonik rejected BASF's €24-per-share cash offer, valued at €11.2 billion, citing weak industrial rationale. Evonik shares fell 23% to €16.75. The company plans restructuring, including divestments and job cuts. Political resistance and RAG Foundation's 43% stake may further complicate the deal.

Original reporting
Published Nov 20, 2026, 6:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 20, 2026, 6:06 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Key facts: Evonik rejects BASF bid; shares fall 23%; restructuring — source image
Decision brief

The 30-second read

High
01

Why it matters

The failed bid eliminates a possible takeover premium, leading to a sharp sell‑off in EVK and heightened scrutiny of BASF's M&A strategy.

02

Market read

The news drives immediate downside risk for EVK and may affect peer valuations in the European chemicals sector.

03

What to watch

Potential regulatory hurdles and political resistance in North Rhine‑Westphalia may have made the bid unattractive regardless of price.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Evonik Industries AG (EVK) is a leading German specialty chemicals group. BASF, a rival chemicals giant, attempted a €11.2 bn cash takeover that was turned down.

Market effects

European chemicals sector may see broader sell‑off as takeover speculation fades.

German market likely to dip on the news, especially peers like BASF.

Limited to chemicals and M&A sentiment; no immediate global macro effect.

Counterpoint

The rejection could signal confidence in Evonik's standalone strategy, presenting a buying opportunity at a discounted price.

Key entities

  • Evonik Industries AG

    German specialty chemicals producer, ticker EVK.

  • BASF SE

    German chemicals conglomerate that made the rejected cash offer.

Related articles

$BAS.DEMed

Evonik shares rise on report BASF prepares renewed takeover offer

BASF (BASFn) is reportedly preparing a renewed takeover offer for Evonik (EVKn) after an earlier €11 billion bid was rejected. BASF is seeking input from German lawmakers and stakeholders to address regulatory and political concerns. Evonik's shares rose 3.3%, while BASF's fell 2.2% on the news. According to Bloomberg, BASF is offering structural guarantees to secure support for the deal.